TETRAPHASE PHARMACEUTICALS INC Depreciation and Amortization
TETRAPHASE PHARMACEUTICALS INC reported Depreciation and Amortization of $200.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2020-03-12
- TETRAPHASE PHARMACEUTICALS INC depreciation, depletion and amortization for the quarter ending 2019-12-31 was $0.00.
- TETRAPHASE PHARMACEUTICALS INC depreciation, depletion and amortization for fiscal 2019 was $200.00K, a 60.00% decline from fiscal 2018.
- TETRAPHASE PHARMACEUTICALS INC depreciation, depletion and amortization for fiscal 2018 was $500.00K, a 16.01% increase from fiscal 2017.
- TETRAPHASE PHARMACEUTICALS INC depreciation, depletion and amortization for fiscal 2017 was $431.00K.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month | Depreciation, Depletion and Amortization 12 month as first filed |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $200.00K 10-K · filed 2020-03-12 | ||
| 2019-09-30 | $200.00K 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | $500.00K 10-K · filed 2020-03-12 | $479.00K 10-K · filed 2019-03-15 | ||
| 2017-12-31 | $431.00K 10-K · filed 2019-03-15 |